Outcomes of small cell lung cancer (SCLC) chemotherapy. Results of a retrospective analysis.

被引:0
作者
Genestreti, G [1 ]
Tassinari, D [1 ]
Pasquini, E [1 ]
Papi, M [1 ]
Roudnas, B [1 ]
Fochessati, F [1 ]
Fantini, M [1 ]
Poggi, B [1 ]
Agostini, V [1 ]
Ravaioli, A [1 ]
机构
[1] City Hosp, Rimini, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7277
引用
收藏
页码:685S / 685S
页数:1
相关论文
共 50 条
  • [31] Quality of life in non small cell lung cancer patients treated with chemotherapy.
    de Pablo, MEH
    Herrero, CC
    Martin, MPB
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S70 - S70
  • [32] A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC).
    Okamoto, H
    Kudoh, H
    Nagatomo, A
    Kunikane, H
    Watanabe, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 669S - 669S
  • [33] THE ROLE OF MAINTENANCE CHEMOTHERAPY(CT) IN SMALL-CELL LUNG CANCER(SCLC) TREATMENT
    DEMARINIS, F
    MACCONE, C
    PALLETTA, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A50 - A50
  • [34] Extensive small cell lung cancer (SCLC) chemotherapy: A population kinetics assessment.
    Stewart, David J.
    Brule, Stephanie Yasmin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] SEQUENTIAL ALTERNATING COMBINATION CHEMOTHERAPY + RADIOTHERAPY IN SMALL CELL LUNG-CANCER (SCLC)
    SCHUETTE, J
    NIEDERLE, N
    KRISCHKE, W
    SEEBER, S
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 177 - 177
  • [36] Dose intensive chemotherapy in patients with advanced small cell lung cancer (SCLC): Preliminary results of a multicenter randomized trial
    Pujol, JL
    Douillard, JY
    Riviere, A
    Poudenx, M
    Quoix, E
    Spaeth, D
    Chomy, P
    Lafitte, JJ
    Monnier, A
    Milleron, B
    Berthaud, P
    LeChevalier, T
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 78 - 78
  • [37] Why do some patients with small cell lung cancer (SCLC) not get chemotherapy?
    Mackean, M.
    Allen, A.
    Price, A.
    Ironside, J.
    Erridge, S.
    Campbell, S.
    Patrizio, A.
    Fergusson, R.
    LUNG CANCER, 2012, 75 : S59 - S59
  • [38] Phase II study of fenretinide in patients with small cell lung cancer (SCLC) with progression after first- or second-line chemotherapy.
    Schneider, BJ
    Worden, F
    Gadgeel, S
    Hodges, C
    Parchment, R
    Zwiebel, J
    Kraut, M
    Kalemkerian, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 690S - 690S
  • [39] Small cell lung cancer (SCLC): Analysis of 100 consecutive cases
    Coll, I
    RodriguezCarballeira, M
    Bastus, R
    Rami, R
    Heredia, JL
    Gonzalez, G
    Cirera, L
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 259 - 261
  • [40] Reduction of the risk of transfusion in patients with small cell lung cancer (SCLC) undergoing chemotherapy
    Thatcher, N
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 234 - 234